{"Symbol": "RMD", "AssetType": "Common Stock", "Name": "ResMed Inc", "Description": "ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.", "CIK": "943819", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL INSTRUMENTS & SUPPLIES", "Address": "9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO, CA, UNITED STATES, 92123", "OfficialSite": "https://www.resmed.com", "FiscalYearEnd": "June", "LatestQuarter": "2025-12-31", "MarketCapitalization": "36863787000", "EBITDA": "2024966000", "PERatio": "25.0", "PEGRatio": "1.671", "BookValue": "43.39", "DividendPerShare": "2.26", "DividendYield": "0.0092", "EPS": "10.1", "RevenuePerShareTTM": "36.9", "ProfitMargin": "0.275", "OperatingMarginTTM": "0.352", "ReturnOnAssetsTTM": "0.147", "ReturnOnEquityTTM": "0.257", "RevenueTTM": "5398119000", "GrossProfitTTM": "3318461000", "DilutedEPSTTM": "10.1", "QuarterlyEarningsGrowthYOY": "0.145", "QuarterlyRevenueGrowthYOY": "0.11", "AnalystTargetPrice": "297.47", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "8", "AnalystRatingHold": "7", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "0", "TrailingPE": "25.0", "ForwardPE": "22.99", "PriceToSalesRatioTTM": "6.83", "PriceToBookRatio": "5.82", "EVToRevenue": "6.71", "EVToEBITDA": "17.34", "Beta": "0.877", "52WeekHigh": "292.44", "52WeekLow": "198.14", "50DayMovingAverage": "252.89", "200DayMovingAverage": "259.86", "SharesOutstanding": "145678000", "SharesFloat": "144771000", "PercentInsiders": "0.506", "PercentInstitutions": "68.581", "DividendDate": "2026-03-16", "ExDividendDate": "2026-02-12"}